Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- (±)-?-methyl-4-(2-methylpropyl)-benzeneacetic acid
- Correlated keywords
- cyclooxygenase NSAIDs nonsteroidal antiinflammatory cox1 cox2 ibuprophen isobutylphenyl propanoic acid isobutylhydratropic act 3 act3 actiprofen actron adex 200 adran alaxan algi-flanderil algiflanderil algiflex algofen am-fam 400 amfam amibufen anafen anco andran anflagen antarene antiflam anti-flam apo apoibuprofen apsifen artofen artil 300 atril BC 1054 BC1054 balkaprogen betaprogen bloom bluton noosten brofen 400 bruflam brufort brustan-N buburone buluofen buprol burana butacortelone butylenin caldolor carol cetafen cobo codral period pain dansida deep relief dentigoa dibufen dolgin boldirid dolgit dolmaral dolo-dolgit dolocyl dolofen F dolomax donjust B doretrim dorival drin easifon ebifac emflam epobron espen femadon fenbid fenspan focus genafen gofen fynofug haltran IB 100 IB100 IP 82 IP82 ibosure obren ibu-attritin ibuattritin ibutab tab slow ibuslow ibuhexal hexal ibudex ibufen ibuflam ibuflamar ibuflamol ibufug ibugen ibugesic ibuleve ibulgan ibumetin ibupirac ibupril ibuprocin ibuprogen ibuprohm ibusal ibutad ifen inabrin inflam inza ipren iprogel irfen isodol juilifen lamidon librofem lidifen liptan lopane medprofen mensoton moment momentact act multifen mynosedin NSC 256854 NSC 256854 nagifen D napacetin nobafon nobfelon nobgen noritis norton novogen novoprofen buprin bureflex nurofen omafen optifen opturem ostarin ostofen paduden panafen pantrop paucofen paxofen pedea pediaprofen pedifen perofen proartinal profen proflex prontalgin proris provil provon quadrax rd 13621 rd13621 rafen ranofen recidol relcofen roidenin rufin rupan seclodin spedifen zambon stelar suspren syntofene tabalon 400 tarein tatanal tofen trendar U 18753 U18753 unipron upfen upofen urem zafen aofen
- Product Overview:
(±)-Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) and non-selective COX inhibitor (IC50s = 2.6 and 1.3 µM for human recombinant COX-1 and COX-2, respectively).{1364} In vivo, (±)-ibuprofen inhibits late-phase formalin-induced paw licking in mice (ED50 = 6.1 mg/kg).{57951} It also inhibits acetic acid-induced writhing in mice (ED50 = 0.47 mg/kg). Formulations containing (±)-ibuprofen have been used in the treatment of fever and mild to severe pain.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.